Global Cord Blood (CO) Stock Price, News & Analysis

Company Overview

Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, was a China-based provider of umbilical cord blood banking services. The company collected, tested, processed and cryopreserved cord blood stem cells for families seeking long-term storage and for patients requiring stem-cell transplants.

Through its operating subsidiaries and affiliated cord blood banks, the company served customers in several major Chinese markets, including Beijing, Guangdong and Zhejiang. Its services generally included customer enrollment, cord blood collection coordination, laboratory processing, preservation and the release of stored units for approved medical use. Cord blood stem cells may be used in the treatment of certain blood-related disorders and other diseases.

The business was established in the early 2000s and expanded through a network of licensed cord blood banks in China. It was publicly traded in the United States under the symbol CO and adopted the Global Cord Blood Corporation name after previously operating as China Cord Blood Corporation. Available public information does not provide sufficient current detail to identify the company’s present leadership or operating status.

Key Stats

• Today's Range: $0.95 to $0.95
• 50-Day Range: $0.95 to $0.95
• 52-Week Range: $2.03 to $5.50
• Volume: 20,005 shs
• Average Volume: 216,519 shs
• Market Capitalization: $115.60 million
• P/E Ratio: 1.49
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/26/2018
• Today: 10/27/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: NYSE:CO
• CIK: 1467808
• Web: www.globalcordbloodcorp.com
• Phone: (523) 605-8180
• Fax: 852-3605-8181
• Employees: 1,202
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.49
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.24 billion
• Price / Sales: 0.09
• Cash Flow: $0.23 per share
• Price / Cash Flow: 4.19
• Book Value: $6.34 per share
• Price / Book: 0.15

Miscellaneous

• Outstanding Shares: 121,551,000
• Free Float: N/A
• Market Cap: $115.60 million
• Optionable: No Data
• Beta: 0.16